XENE Q3 2022 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

XENEXenon Pharmaceuticals Inc.

$5B

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$132,000-98.4% YoY

Gross Profit

-$29M-22196.2% margin

Operating Income

-$38M-28884.8% margin

Net Income

-$37M-28143.9% margin

EPS (Diluted)

$-0.57

QoQ Revenue Growth

-75.4%

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$31M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$776M

Total Liabilities

$23M

Stockholders' Equity

$753M

Cash & Equivalents

$103M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$132,000	$8M	-98.4%
Gross Profit	-$29M	-$11M	-172.1%
Operating Income	-$38M	-$16M	-144.4%
Net Income	-$37M	-$15M	-140.5%

Revenue Segments

License And Service

$132,000100%